Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER79245971FILING DATE07/12/2018
REG NUMBER0000000REG DATEN/A
REGISTERPRINCIPALMARK TYPETRADEMARK
INTL REG #1435634INTL REG DATE07/12/2018
TM ATTORNEYGOODWIN, KATRINA JOYE
L.O. ASSIGNEDO30-NOT FOUND

PUB INFORMATION

RUN DATE04/11/2020
PUB DATEN/A
STATUS653-SUSPENSION LETTER - MAILED
STATUS DATE01/27/2020
LITERAL MARK ELEMENTSATURN

DATE ABANDONEDN/ADATE CANCELLEDN/A
SECTION 2FNOSECTION 2F IN PARTNO
SECTION 8NOSECTION 8 IN PARTNO
SECTION 15NOREPUB 12CN/A
RENEWAL FILEDNORENEWAL DATEN/A
DATE AMEND REGN/A


FILING BASIS

FILED BASISCURRENT BASISAMENDED BASIS
1 (a)NO1 (a)NO1 (a)NO
1 (b)NO1 (b)NO1 (b)NO
44DNO44DNO44DNO
44ENO44ENO44ENO
66AYES66AYES

NO BASISNONO BASISNO


MARK DATA

STANDARD CHARACTER MARKYES
LITERAL MARK ELEMENTSATURN
MARK DRAWING CODE4-STANDARD CHARACTER MARK
COLOR DRAWING FLAGNO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME FUJIFILM Diosynth Biotechnologies UK Limited
ADDRESSBelasis Avenue
Billingham TS23 1LH
ENTITY16-LTD LIAB CO
CITIZENSHIPGB8

GOODS AND SERVICES

INTERNATIONAL CLASS 001
          DESCRIPTION TEXT Cell culture media for scientific and research use; Chemicals for use in biotechnological manufacturing processes, namely, mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for manufacture and development in the biotechnology industries
INTERNATIONAL CLASS 040
          DESCRIPTION TEXT Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Scientific, industrial and technical research, development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; Scientific project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; excluding from all of the foregoing research and development of vaccines and medicines

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 001FIRST USE DATENONEFIRST USE IN COMMERCE DATENONECLASS STATUS6-ACTIVE
INTERNATIONAL CLASS 040FIRST USE DATENONEFIRST USE IN COMMERCE DATENONECLASS STATUS6-ACTIVE
INTERNATIONAL CLASS 042FIRST USE DATENONEFIRST USE IN COMMERCE DATENONECLASS STATUS6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATIONNO

SECTION 66A INTERNATIONAL REGISTRATION DATA

INTL REG #1435634
INTL REG DATE07/12/2018
PRIORITY CLMDYES
PRIOR CLMD DATE01/23/2018
INTL STATUS 001-REQUEST FOR EXTENSION OF PROTECTION PROCESSED
INTL STATUS DATE11/22/2018
AUTO PROTECTION DATE05/22/2020
INTL RENEWAL DATE07/12/2028
INTL REG DEATH DATEN/A
FIRST REFUSALYES

PROSECUTION HISTORY

DATEENT CDENT TYPEDESCRIPTIONENT NUM
04/10/2020TEMEITEAS/EMAIL CORRESPONDENCE ENTERED 029
04/10/2020CRFAICORRESPONDENCE RECEIVED IN LAW OFFICE 028
04/10/2020ERSIITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED 027
01/27/2020GNS3ONOTIFICATION OF LETTER OF SUSPENSION E-MAILED 026
01/27/2020GNSLSLETTER OF SUSPENSION E-MAILED 025
01/27/2020CNSLRSUSPENSION LETTER WRITTEN 024
12/31/2019TEMEITEAS/EMAIL CORRESPONDENCE ENTERED 023
12/30/2019CRFAICORRESPONDENCE RECEIVED IN LAW OFFICE 022
12/30/2019ERSIITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED 021
07/25/2019GNS3ONOTIFICATION OF LETTER OF SUSPENSION E-MAILED 020
07/25/2019GNSLSLETTER OF SUSPENSION E-MAILED 019
07/25/2019CNSLRSUSPENSION LETTER WRITTEN 018
07/02/2019TEMEITEAS/EMAIL CORRESPONDENCE ENTERED 017
07/02/2019CRFAICORRESPONDENCE RECEIVED IN LAW OFFICE 016
07/02/2019TROAITEAS RESPONSE TO OFFICE ACTION RECEIVED 015
03/18/2019ARAAIATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED 014
03/18/2019REAPITEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED 013
02/02/2019RFNPPREFUSAL PROCESSED BY IB 012
01/12/2019RFCSPNON-FINAL ACTION MAILED - REFUSAL SENT TO IB 011
01/12/2019RFRRPREFUSAL PROCESSED BY MPU 010
01/01/2019RFCRENON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW 009
12/31/2018CNRTRNON-FINAL ACTION WRITTEN 008
12/21/2018RFWRPNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW 007
12/04/2018RFCRENON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW 006
12/03/2018CNRTRNON-FINAL ACTION WRITTEN 005
11/30/2018MAFROAPPLICATION FILING RECEIPT MAILED 004
11/26/2018DOCKDASSIGNED TO EXAMINER 003
11/26/2018NWOSINEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
11/22/2018REPRMSN ASSIGNED FOR SECT 66A APPL FROM IB 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEYSuzanne M. Hengl
CORRESPONDENCE ADDRESSSuzanne M. Hengl
Baker Botts L.L.P.
44th Floor
30 Rockefeller Plaza
New York NY 10112-4498
DOMESTIC REPRESENTATIVENONE